Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
03/2003
03/13/2003US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders
03/13/2003CA2458859A1 (alpha)-haloenamine reagents
03/13/2003CA2458555A1 Use of c2-substituted indane-1-one systems for producing medicaments for the prophylaxis or treatment of obesity
03/13/2003CA2458553A1 Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity
03/13/2003CA2458552A1 Use of derivatives of c2-substituted indan-1-ol systems for producing medicaments for the prophylaxis or the treatment of obesity
03/13/2003CA2458526A1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity
03/13/2003CA2458521A1 Derivatives of c2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments
03/13/2003CA2457922A1 Novel pyrazole analogs acting on cannabinoid receptors
03/13/2003CA2422135A1 Urea derivatives and adhesion molecule inhibitors containing the same as effective ingredients
03/12/2003EP1290198A2 Vectors for dna delivery
03/12/2003EP1289983A2 Heteroarylalkanoic acids as integrin receptor antagonists
03/12/2003EP1289960A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
03/12/2003EP1289949A1 Method for the production of caprolactam
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP1289931A1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
03/12/2003EP1289526A1 Melanocortin receptor agonists
03/12/2003EP1036058B1 Adamantane derivatives
03/12/2003EP0900198B1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/12/2003EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof
03/12/2003EP0729459B1 Phenyl-alkyl imidazoles as h3-receptor antagonists
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1401634A 4-guanidinobenzamides antifertility compounds
03/12/2003CN1401621A Intermediate for preparing tricyclic compound and preparing method thereof
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531604 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect.
03/11/2003US6531495 Potassium channel
03/11/2003US6531241 Anions of equal number to cations to maintain charge neutrality, are disclosed. These spacer groups may be organic or inorganic in origin and may vary in length. The spacer groups may be saturated, containing single bonds, or may have
03/11/2003CA2121230C 1,3-dihydro-2h-imidazo(4,5-b) quinolin-2-one derivatives
03/11/2003CA2102187C Use of atipamezole for the treatment of male sexual impotence
03/06/2003WO2003018562A1 Process for distilling alkaline caprolactam product at reduced pressure
03/06/2003WO2003018552A2 Aromatic and heteroaromatic acid halides for synthesizing polyamides
03/06/2003WO2003018550A1 Process for recovering caprolactam from aqueous caprolactam product using in situ prepared alkali amino caproate
03/06/2003WO2003018543A1 Novel cyclohexyl sulphones
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003WO2003018008A1 Apo ai expression accelerating agent
03/06/2003US20030045755 Polyamine analogues as cytotoxic agents
03/06/2003US20030045729 Process for producing optically active hemiesters
03/06/2003US20030045726 Novel immunotherapeutic agents
03/06/2003US20030045581 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/06/2003US20030042471 Conjugated copolymers of dithienothiophene with vinylene or acetylene
03/06/2003CA2458616A1 Aromatic and heteroaromatic acid halides for synthesizing polyamides
03/06/2003CA2456420A1 Novel cyclohexyl sulphones
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1288197A2 N-Unsubstituted amidinium salts
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286953A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
03/05/2003EP1286704A2 Ethylenedicysteine (ec)-drug conjugates
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP0966447B1 Small molecules useful in the treatment of inflammatory disease
03/05/2003EP0939628B1 Thiol sulfone metalloprotease inhibitors
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0669913B1 Detection of hypoxia
03/05/2003CN1400974A Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1102595C Penems and their derivatives
03/05/2003CN1102582C Process for preparation of alkylimidazolidone (meth) acrylates
03/04/2003US6528678 Phosgene-free process for preparing carbamates
03/04/2003US6528655 Aromatic derivatives with HIV integrase inhibitory properties
03/04/2003US6528654 Synthesis of histamine dihydrochloride
03/04/2003US6528653 Thienopyrrolidinones
03/04/2003US6528543 Glucokinase activating for treating type II diabetes; acylurea compound, phenylacetyl-substituted; 1-(2-(3-chloro-phenyl)-3cyclopentyl-propionyl)-3-methyl-urea
03/04/2003US6528535 Bicyclic inhibitors of protein farnesyl transferase
03/04/2003US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
03/04/2003US6528510 HIV protease inhibitors
02/2003
02/28/2003WO2002018331A1 Herbicidal benzoyl cyclohexane dione
02/28/2003CA2420917A1 Herbicidally active benzoylcyclohexanediones
02/27/2003WO2003016306A1 Hiv inhibiting pyrimidines derivatives
02/27/2003WO2003016291A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ
02/27/2003WO2003016285A1 Method of preparing 4-(imidazole-1-il)benzenesulphonamide derivatives
02/27/2003WO2003016266A1 β-KETOAMIDE COMPOUNDS AND MEDICINAL USE THEREOF
02/27/2003WO2003015774A1 Compounds effecting glucokinase
02/27/2003WO2003015518A1 Method for controlling particular insect pests by applying anthranilamide compounds
02/27/2003WO2002096884A3 Substituted benzoylketones as herbicidal agents for use as plant treatment agent
02/27/2003WO2002092129A3 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist
02/27/2003WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof
02/27/2003WO2002038105A3 Novel polyamine analog-amino acid conjugates useful as anticancer agents
02/27/2003WO2001097860A3 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
02/27/2003US20030040644 Synthesis of nitroalcohol diastereomers
02/27/2003US20030040630 Method for producing sulfonyl imidazole derivatives
02/26/2003EP1285653A1 Use of alpha-1L agonists in the treatment of incontinence
02/26/2003EP1284730A1 Aralkyl ester soft drugs
02/26/2003EP0979034B1 Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same
02/26/2003EP0823898B1 Hydantoine derivatives as intermediate products for active pharmaceutical agents
02/26/2003CN1399631A Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
02/26/2003CN1399622A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
02/25/2003US6525215 HIV protease inhibitors
02/25/2003US6525082 Apoptosis inducer
02/25/2003US6525042 Sulfonyl derivatives
02/25/2003US6525036 Compounds and compositions as protease inhibitors
02/21/2003WO2002024660A1 Imidazole derivatives or their salts
02/21/2003WO2002016328A1 Biphenyl derivatives and the use thereof as integrin inhibitors
02/21/2003CA2420945A1 Imidazole derivatives or their salts
02/21/2003CA2420208A1 Biphenyl derivatives and their use as integrin inhibitors
02/20/2003WO2003014296A2 A group of novel anti-cancer compounds with specific structure
02/20/2003WO2003014079A1 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
02/20/2003WO2003013526A1 Anticoagulant compounds
02/20/2003WO2003013518A1 Alpha-ketoamide derivatives as cathepsin k inhibitors
02/20/2003WO2003013515A1 Novel alpha adrenergic agents
02/20/2003WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
02/20/2003WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 345